Background: Chagas-Mazza disease, usually considered a neglected tropical diseases, is an important cause of morbidity and mortality in Latin America. Treatment in adult chronic asymptomatic patients is still in debate. Main limitations of traditional drugs are the adverse drug reactions (ADRs). Nevertheless treatment of young adults and women of childbearing age is proposed to be useful in decreasing progression to cardiovascular disease and mother to child transmission.Our objective is to evaluate tolerance and development of ADRs with benznidazol (BZN) in adult chronic asymptomatic patients with Chagas, in four public medical centers in Ciudad Aut贸noma de Buenos Aires (CABA), a non-endemic area.Methods & Materials: We conducted a descriptiveobservational study of ADRs related to BZN treatment in four medical centers in CABA from 01/06/2012 to 31/12/2018. Patients between 18 and 65 years, without cardiovascular or digestive disease and Kushnir score of 0-1 were included. Pregnant or breastfeeding women, older than 65 years, or with Kushnir score 2-3 were excluded.Included patients signed an informed consent, were advised on risks-benefits of the medication and prescribed recommendations to improve tolerance. BZN was used at 5 mg/kg dose for 60 days. Daily self-monitoring records and weekly medical controls were performed. Telephone contacts were provided in case of eventualities Results: We included 106 patients (85 female and 21 male) with a median age of 36.7 years (18-60). The ADRs were observed in 56/106 (52.8%) of the patients. Of the total of patients; 80/106 (75.4%) completed the treatment and 26/106 (24.6%) did not complete it. Of those who did not complete, 21/26 presented ADRs, with only 6/21 (28.5%) being suspended at the request of the treating team. Of all the ADRs; 67/79 (84.8%) were mild and 6/106 (5.6%) severe. Only 1 patient (0.9%) required hospitalization and no deaths attributable to ADRs were observed. Conclusion:In our experience, BZD was safe in adults. Tolerance was acceptable and most of the adverse events were gastrointestinal and cutaneous, were mild and could be managed with symptomatic treatment with no mortality observed.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations鈥揷itations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright 漏 2024 scite LLC. All rights reserved.
Made with 馃挋 for researchers
Part of the Research Solutions Family.